๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB ยท Real-Time Price ยท USD
1.240
-0.090 (-6.77%)
At close: Nov 20, 2026, 4:00 PM EST
1.249
+0.009 (0.71%)
After-hours: Nov 20, 2026, 7:34 PM EST

Seres Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.130.79---144.93
Revenue Growth
505.41%----336.33%
Gross Profit
-38.08-54.82-68.13-117.6-109.653.04
Operating Income
-66.2-93.97-121.32-195.1-179.91-64.49
Net Income
-46.955.70.14-113.72-250.16-65.58
Earnings Per Share
-4.880.640.00-17.77-46.29-14.30
EPS Growth
-14333.92%----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17.5345.7730.79127.97181.34290.71
Total Debt
35.7782.9791.64198.78162.5949.21
Net Cash (Debt)
-18.24-37.2-60.85-70.8218.75241.5
Net Cash Growth
-----92.23%13.46%
Net Cash Per Share
-1.89-4.19-7.83-11.063.4752.67

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-63.941.12-148.61-117.35-228.826.69
Capital Expenditures
-0.03-0.25-0.38-7.98-9.82-9.57
Free Cash Flow
-63.970.87-148.99-125.33-238.64-2.88
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----2.10%
Operating Margin
-3115.15%-11910.14%----44.50%
Pretax Margin
-2209.55%721.93%----45.25%
Profit Margin
-2209.55%721.93%----45.25%
FCF Margin
-3010.35%109.63%----1.99%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-23.631043.26---
P/FCF Ratio
-155.62----
PS Ratio
5.95170.61---5.28